Clinical and Laboratory Standards Institute document I/LA30-A—Immunoassay Interference by Endogenous Antibodies; Approved Guideline presents information on the origin, nature, and prevalence of circulating endogenous antibodies, which cause interference with immunoassay results. The mechanisms of the interference along with some specific examples are included. To address the problem, recommendations for regulatory bodies, reagent manufacturers, and laboratorians are provided.
CLSI I/LA30-A
Original price was: $257.00.$128.00Current price is: $128.00.
Immunoassay Interference by Endogenous Antibodies; Approved Guideline, ILA30AE
Clinical and Laboratory Standards Institute , 02/01/2008
Related products
-
CLSI EP15-A2
Original price was: $178.00.$89.00Current price is: $89.00. -
CLSI H26A
Original price was: $295.00.$147.00Current price is: $147.00. -
CLSI C03-A4
Original price was: $110.00.$55.00Current price is: $55.00. -
CLSI I03A
Original price was: $180.00.$90.00Current price is: $90.00. -
CLSI QMS09-A2
Original price was: $128.00.$64.00Current price is: $64.00.